Latest news
Neuren Pharmaceuticals (ASX:NEU) in Focus on Biotech Progress - Kalkine MediaKalkine Media · Fri, 07 Aug 2026 10:09:00 GMTWhy Are Westgold (ASX:WGX) and Two ASX Shares in Focus? - Kalkine MediaKalkine Media · Fri, 07 Aug 2026 03:56:00 GMTNeuren Pharmaceuticals (ASX:NEU) in Focus: What Investors Are Watching After a Positive Session? - KalkineKalkine · Thu, 06 Aug 2026 02:40:00 GMTNeuren Pharmaceuticals (ASX:NEU) Soars on Record DAYBUE Sales and Upgraded Royalty Forecast - KalkineKalkine · Wed, 05 Aug 2026 08:06:00 GMTNeuren Rockets on Record DAYBUE Sales as 2026 Royalty Guidance Jumps - KalkineKalkine · Wed, 05 Aug 2026 03:21:00 GMTNeuren Pharmaceuticals Reports Record Q2 DAYBUE Net Sales of US$125m, Upgrades CY26 Royalty Guidance - KalkineKalkine · Wed, 05 Aug 2026 00:55:33 GMTNeuren (ASX:NEU) Reports Continued Growth in DAYBUE Commercial Performance - KalkineKalkine · Wed, 05 Aug 2026 00:45:00 GMTWhy Neuren Pharmaceuticals Ltd (ASX:NEU) Remains in Focus for Biotech Investors - KalkineKalkine · Tue, 04 Aug 2026 12:11:00 GMT